Care.Com Inc (CRCM) 10.06 $CRCM Care.com Introduces

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Care.Com Inc (CRCM) 10.06 $CRCM

Care.com Introduces Groundbreaking Peer-to-Peer Benefits Platform for Caregivers
BusinessWire - Wed Sep 14, 7:00AM CDT
Care.com (NYSE:CRCM), the world's largest online marketplace for finding and managing family care, today announced the expansion of Care.com Benefits with a first-of-its-kind peer-to-peer benefits platform between families and caregivers that represents an important step forward in professionalizing caregiving and developing a social safety net for millions of care workers in the on-demand gig economy.
CRCM: 10.06 (+0.01)

Commit To Purchase Care.com At $7.50, Earn 7.7% Annualized Using Options
StockOptionsChannel.com - Tue Sep 13, 10:41AM CDT
Investors considering a purchase of Care. om Inc stock, but cautious about paying the going market price of $9.75/share, might benefit from considering selling puts among the alternative strategies at their disposal.
CRCM: 10.06 (+0.01)

Should You Get Rid of Care.com (CRCM) Now?
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 7:44AM CDT
Care.com (CRCM) has witnessed a significant price decline and negative trend in earnings estimate revisions in the past four weeks
CRCM: 10.06 (+0.01), OUTR: 51.98 (-0.01)

On BizWireTV: A Brewer Revolutionizes Small Business Finance and Start Watching Television, Without a TV
BusinessWire - Fri Aug 12, 7:08AM CDT
--Featuring BrewDog, Care.com, WWE 2K17 and Yahoo
TTWO: 45.93 (+0.69), YHOO: 43.93 (+1.14), PG: 86.83 (-1.75), CRCM: 10.06 (+0.01)

Child Care Spending is Now More Than 10% of Household Income for Majority of Families
BusinessWire - Mon Aug 08, 9:49AM CDT
According to the Care.com 2016 Cost of Care Survey, 54% of families spend more than 10% of their annual household income on child care. In the last year, as housing costs have climbed to rival child care costs as top expenses, families are recognizing the need to budget for child care more than ever before. In fact, the third annual survey from Care.com (NYSE: CRCM, www.care.com), the world's largest online destination for finding and managing family care, found that today, 74% of families budget for child care.
CRCM: 10.06 (+0.01)

Care.com to Participate At Canaccord Genuity 36th Annual Growth Conference
BusinessWire - Tue Aug 02, 3:01PM CDT
Care.com (NYSE: CRCM), the world's largest online destination for finding and managing family care, today announced that Michael Echenberg, Executive Vice President and Chief Financial Officer, will present at the Canaccord Genuity 36th Annual Growth Conference, to be held at InterContinental Boston on Wednesday, August 10, 2016 at 9:00AM ET.
CRCM: 10.06 (+0.01)

The Zacks Analyst Blog Highlights: Intrawest Resorts Holdings, AXT, Care.com, Entegris and ChannelAdvisor
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 8:30AM CDT
The Zacks Analyst Blog Highlights: Intrawest Resorts Holdings, AXT, Care.com, Entegris and ChannelAdvisor
AXTI: 4.97 (+0.19), ECOM: 12.25 (-0.03), ENTG: 16.96 (+0.11), SNOW: 16.54 (+0.05), CRCM: 10.06 (+0.01)

Caring Across Generations, Care.com and New America Launch the "Who Cares" Coalition to Redefine the Social and Economic Value of Care and Caregiving
BusinessWire - Tue Jun 14, 7:00AM CDT
Economic growth depends on all of us having quality care for our loved ones. It is the critical factor in driving female participation in the workforce and the source of jobs for millions of caregivers. Yet, far too often both care and caregiving are devalued in our society. Now a unique coalition of organizations from the corporate and non-profit sector is coming together to elevate the role of care in our economy and society. Caring Across Generations, Care.com, and New America have joined forces to launch the "Who Cares" Coalition (www.whocares.org), a unique partnership that will build upon the existing groundbreaking work of each of the partners to create a new paradigm that better reflects the true social and economic value of care and caregiving.
CRCM: 10.06 (+0.01)

5 Bargain Breakout Stocks Delivering Impressive Returns
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 9:13AM CDT
Stocks breaking above the resistance barrier carry the promise of strong gains.
AXTI: 4.97 (+0.19), ECOM: 12.25 (-0.03), SNOW: 16.54 (+0.05), ENTG: 16.96 (+0.11), CRCM: 10.06 (+0.01)

Care.com Founder, Chairwoman & CEO, Sheila Lirio Marcelo, to Participate in the United State of Women Summit Convened by the White House
BusinessWire - Fri Jun 10, 8:35AM CDT
Care.comFounder, Chairwoman and CEO, Sheila Lirio Marcelo, will participate in The United State of Women Summit convened by the White House in Washington, DC on Tuesday, June 14, 2016. Ms. Marcelo will speak on the "Valuing Caregiving in the 21st Century" panel which will be part of the Summit's "Economic Opportunity" track.
CRCM: 10.06 (+0.01)

H&R Block (HRB) Beats on Earnings in Q4, Hikes Dividend
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 7:15AM CDT
H&R Block Inc. 's (HRB) earnings per share in fiscal fourth-quarter 2016 surpassed Zacks Consensus Estimate.
CRCM: 10.06 (+0.01), WTW: 10.43 (+0.31), INTU: 110.07 (+1.10), HRB: 22.74 (+0.29)

Care.com to Participate At Upcoming Investor Conferences
BusinessWire - Wed May 18, 8:00AM CDT
Care.com (NYSE: CRCM), the world's largest online destination for finding and managing family care, today announced that Michael Echenberg, Executive Vice President and Chief Financial Officer, will participate at the following upcoming conferences:
CRCM: 10.06 (+0.01)

Can The Uptrend Continue for Care.com (CRCM)?
Zacks Equity Research - Zacks Investment Research - Tue May 17, 8:36AM CDT
Investors certainly have to be happy with Care.com, Inc. (CRCM) and its short term performance.
CRCM: 10.06 (+0.01)

Care.com (CRCM): Strong Industry, Solid Earnings Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Tue May 17, 7:55AM CDT
Care.com (CRCM) is seeing good earnings estimate revision activity, and is well positioned from a Zacks Industry Rank perspective
CRCM: 10.06 (+0.01)

Surging Earnings Estimates Signal Good News for Care.com (CRCM)
Zacks Equity Research - Zacks Investment Research - Fri May 13, 7:52AM CDT
Care.com (CRCM) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision.
CRCM: 10.06 (+0.01)

Care.com to Present At Upcoming Investor Conferences
BusinessWire - Wed May 04, 8:00AM CDT
Care.com (NYSE: CRCM), the world's largest online destination for finding and managing family care, today announced that management will present at the following upcoming conferences:
CRCM: 10.06 (+0.01)

Care.com beats 1Q profit forecasts
Automated Insights - Thu Apr 28, 5:47AM CDT
WALTHAM, Mass. (AP) _ Care.com Inc. (CRCM) on Thursday reported first-quarter net income of $6.8 million, after reporting a loss in the same period a year earlier.
CRCM: 10.06 (+0.01)

Care.com Announces First Quarter 2016 Financial Results
BusinessWire - Thu Apr 28, 5:00AM CDT
--Achieves Adjusted EBITDA Profitability Ahead of Schedule
CRCM: 10.06 (+0.01)

New Strong Buy Stocks for April 12th
Zacks Equity Research - Zacks Investment Research - Tue Apr 12, 8:52AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
ALGN: 94.55 (+0.85), BGG: 18.61 (+0.23), BECN: 40.71 (+1.18), CRCM: 10.06 (+0.01), ATRC: 15.83 (-0.14)

Care.com to Announce Fourth Quarter and Full Year 2015 Earnings Results on February 23, 2016
BusinessWire - Tue Jan 26, 8:00AM CST
Care.com, Inc. (NYSE: CRCM), the world's largest online destination for finding and managing family care, will announce its financial results for the fourth quarter and full year ended December 26, 2015 on Tuesday, February 23, 2016.
CRCM: 10.06 (+0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Valmet Expands Board Maker Deal in Asia With New Line

Updated Category News Views 87

If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...

Continue Reading
O-I Glass Faces Class Action: Investor Implications

Updated Category News Views 68

O-I Glass in Hot Water Over Misleading Statements I'll tell you, nothing gets my goat quite like uncovering deceptive practices in the corporate world. It seems O-I Glass, Inc. (NYSE: OI), might have played a fast one with its shareholders. The company is staring down the barrel of a class action lawsuit from Schall, Brown & Schwartz LLP, alleging they weren't entirely...

Continue Reading
KT&G Launches Heated Tobacco in Kazakhstan's Market

Updated Category News Views 43

KT&G Lights Up Kazakhstan In a bold move, KT&G is laying down the gauntlet in Kazakhstan's tobacco market, introducing its cutting-edge heated tobacco gizmo and a handful of sleek FAIIM sticks. Launching this October, these aren't just any devices—they're the FLEX locals have been waiting for, rebranded from South Korea's lil AIBLE and AIIM but made to fit right in with...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 178

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 730

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 323

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 226

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Niagara Networks Boosts TLS 1.3 Decryption to 90+ Gbps

Updated Category News Views 73

In a digital era where encryption is racing ahead like a runaway train, Niagara Networks has stepped up with some serious muscle enhancements to their ePacketron platform. They're not just playing catch-up with the latest TLS 1.3 decryption capabilities; they're leading the charge with a robust over 90 Gbps performance—no small feat in today's encrypted traffic...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 490

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 228

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
aria-label="Continue reading: JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer"> Continue Reading